Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health”or the “Company”) reports that the Management Cease Trade Order granted by the British Columbia Security Commission on May 2, 2019 was lifted effective June 3, 2019 following the filing of the Company’s financial statements and accompanying management’s discussion and analysis for the fiscal year ended December 31, 2018.
- AVRICORE HEALTH ANNOUNCES $1.5 MILLION FINANCING
- Avricore Health’s HealthTab™ Achieves Critical Milestones in Connecting New Testing Device
- HealthTab™ Integrating New Device to Add HbA1c Blood Glucose Testing to Its Real-Time Data Reporting System
- Avricore Health’s HealthTab to Enable Real Time Reporting of COVID-19 Results in Pharmacy
- AVRICORE HEALTH ANNOUNCES SHARES FOR DEBT TRANSACTION
AVRICORE HEALTH ANNOUNCES $1.5 MILLION FINANCING
adminOctober 14, 2020